Aarin Capital
We seek to create long-term value by partnering with talented, hungry management teams actively complementing their skills with our
Business Model:
Revenue: $7.4M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Aarin Capital Information
Geographic Data
Address: 70 Millers Road
City: Inn Bangalore
State: karnataka
Zip: 560052
Country: IN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
We seek to create long-term value by partnering with talented, hungry management teams actively complementing their skills with our collaborative engagement. We aim to build profitable companies with sustainable value propositions. We appreciate audacious ideas that embed disruptive, customer-focused technologies with the potential to address and transform large markets. We support our investee companies in generating profitable revenue growth, instituting strong compliance and governance processes, margin enhancement and active operational and strategic management. We dislike financial engineering as a means to demonstrating value creation. We encourage our investee companies to focus on maximising free cash flows by focusing on their core strengths. We are not merely financial investors but also trusted operating partners of our investee companies. Accordingly, we have separate investment and operating teams comprising seasoned, high-quality professionals with a wealth of hands-on operating and investing experience to streamline and maximise the impact and support we can provide to our investee companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2016 | Zumutor Biologics | Seed Round | 11.5M |
| 2/2016 | Tracxn | Venture Round | - |
| 9/2013 | BYJU’S | Series A | 9M |
| 7/2015 | BYJU’S | Series B | 25M |
| 5/2013 | Invictus Oncology | Series A | 0 |
| 9/2021 | 88academics | Seed Round | 0 |
| 8/2014 | Vyome Therapeutics | Series B | 8M |
| 7/2016 | Zimmber | Series A | 5M |
| 3/2018 | FOODLINK | Venture Round | 0 |
| 10/2015 | Faircent | Venture Round | - |
| 10/2013 | Theramyt Novobiologics | Series A | 4.5M |
| 5/2015 | KleverKid | Seed Round | - |
| 6/2016 | Fabhotels | Series A | 8M |
| 6/2016 | Campus Diaries | Seed Round | 220k |
| 1/2016 | SavvyMob | Seed Round | 1M |
| 7/2015 | Tripfactory | Series A | 10M |
| 12/2016 | Pocket Aces | Equity | 3M |
| 5/2016 | Faircent | Series A | - |
| 2/2016 | Oust Labs | Seed Round | - |
| 9/2012 | Vyome Therapeutics | Series A | 0 |
| 8/2016 | Vyome Therapeutics | Series C | 14M |
| 5/2016 | Thinkster Math | Series A | 0 |
| 9/2017 | Sayre Therapeutics | Equity | 8M |
| 3/2017 | PharmEasy | Series B | 0 |
| 2/2016 | Magic Crate | Seed Round | - |
| 7/2018 | Magic Crate | Seed Round | - |
| 3/2016 | PharmEasy | Series A | 5M |
| 9/2014 | EdCast | Series A | 6M |
| 10/2016 | Impact Analytics | Seed Round | 750k |
| 2/2015 | HomeLane | Series A | 4.5M |
| 6/2013 | Thinkster Math | Seed Round | 1M |
| 12/2017 | Faircent | Series B | 0 |
| 11/2016 | DoSelect | Seed | 490k |
| 3/2017 | Wigzo Technologies | Venture Round | - |
| 7/2015 | Zimmber | Seed Round | 2M |
| 9/2015 | UE LifeSciences | Series A | 3M |
| 2/2016 | Invictus Oncology | Series A | - |
| 8/2016 | HomeLane | Series B | 6M |
| 9/2021 | 88academics | Seed Round | 0 |
| 7/2018 | Magic Crate | Seed Round | - |
| 3/2018 | FOODLINK | Venture Round | 0 |
| 12/2017 | Faircent | Series B | 0 |
| 9/2017 | Sayre Therapeutics | Venture Round | 0 |
| 3/2017 | PharmEasy | Series B | 0 |
| 3/2017 | Wigzo Technologies | Venture Round | - |
| 12/2016 | Pocket Aces | Series A | 0 |
| 11/2016 | DoSelect | Seed Round | 0 |
| 10/2016 | Impact Analytics | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
